JILL MILLER: Open Payments
NPI 1023070612 · SAINT PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 20 payments from 9 companies in 2025. Trend: 2023 $843 · 2024 $436 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 5 | $150 |
| Astellas Pharma US Inc | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| ABBVIE INC. | 2 | $44 |
| Novo Nordisk Inc | 2 | $43 |
| Becton, Dickinson and Company | 1 | $27 |
| MILLICENT US INC | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Sage Therapeutics, LLC | 1 | $21 |
Products named: Veozah, LILETTA, Wegovy, Mirena, BD Veritor Plus Analyzer, FEMLYV, Qelbree, ZURZUVAE.
Industry payments across FL — which companies pay providers there.
